NCT02851654

Brief Summary

Dry eye syndrome is a benign situation however its impact on patient's quality of live and on health system is not trivial. One problem is the lack of correlation between patient's symptoms and physical sign observed on slit lamp examination. Eye blinking is a parameter of increased interest in this pathology particularly its frequency. To date no treatment of dry eye syndrome has a proven impact on eye blinking frequency. However recording of blinks has mostly been performed on short duration (3 to 5 minutes) and the distribution of intervals between 2 blinks is not gaussian but exponential. In this study, it is proposed to use modern eye-movement recorder to measure the blink frequency on longer duration (12 minutes) while reading on a screen computer and during a face-to-face interview before and after treatment of meibomian gland dysfunction responsible of moderate to severe dry eye syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 5, 2014

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

July 28, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 1, 2016

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2019

Completed
Last Updated

December 11, 2019

Status Verified

December 1, 2019

Enrollment Period

5 years

First QC Date

July 28, 2016

Last Update Submit

December 10, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • duration between 2 blinks

    Assessment by infrared oculography while the patient is reading on a computer screen and during a face-to-face interview

    2 months after treatment

Study Arms (1)

Dry eye syndrome

Meibomian gland dysfunction responsible of moderate to severe dry eye syndrome

Device: Infrared oculography

Interventions

The infrared oculography provides binocular recordings and allows simultaneous measurement of horizontal and vertical eye movements.

Dry eye syndrome

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with moderate to severe dry eye syndrome from meibomian gland dysfunction

You may qualify if:

  • Moderate to severe dry eye syndrome (Ocular Surface Disease Index\> 30) following a meibomian gland dysfunction
  • Not yet properly treated for a meibomian gland dysfunction

You may not qualify if:

  • History of other ophthalmological or neurological disease
  • Pregnant or breastfeeding women
  • Patient under 18 years old
  • Patient under legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Ophtalmologique Adolphe de Rothschild (FOR)

Paris, 75019, France

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2016

First Posted

August 1, 2016

Study Start

November 5, 2014

Primary Completion

October 30, 2019

Study Completion

October 30, 2019

Last Updated

December 11, 2019

Record last verified: 2019-12

Locations